C43.122 — Malignant melanoma of left lower eyelid, including canthus
Is C43.122 billable?
Yes — C43.122 is billable for FY2027. C43.122 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. C43.122 may be submitted for encounters from October 1, 2026 through September 30, 2027.
C43.122 at a glance
| Code | C43.122 |
|---|---|
| Description | Malignant melanoma of left lower eyelid, including canthus |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does C43.122 group to?
C43.122 sits in MDC 02 and helps define the logic of 2 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 124Other Disorders of the Eye with MCC or Thrombolytic Agentmedical
- 125Other Disorders of the Eye without MCCmedical
How is C43.122 listed in the Alphabetic Index?
The Alphabetic Index lists these routes under C43.1, the nearest indexed parent of C43.122. Use them to find the family, then select the specific code.
- Melanoma › skin › canthus (malignant)
- Melanoma › skin › eyelid (malignant)
- Melanoma › skin › palpebra (malignant)
Excludes1 — never code together — inherited from C43
The conditions below can never be reported together with C43.122 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- melanoma in situ (D03.-)
Excludes2 — not included here — inherited from C43
The conditions below are not part of C43.122, but a patient may have both at the same time. When documentation supports it, C43.122 and the excluded code may both be reported.
How long has C43.122 existed?
C43.122 first appears in FY2019.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.